What is the share price of Medico Intercontinental Ltd (MIL) today?
The share price of MIL as on 12th June 2025 is ₹40.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Medico Intercontinental Ltd (MIL) share?
The past returns of Medico Intercontinental Ltd (MIL) share are- Past 1 week: -0.22%
- Past 1 month: 13.01%
- Past 3 months: -3.94%
- Past 6 months: -25.89%
- Past 1 year: -8.36%
- Past 3 years: 31.18%
- Past 5 years: 100.55%
What are the peers or stocks similar to Medico Intercontinental Ltd (MIL)?
The peers or stocks similar to Medico Intercontinental Ltd (MIL) include:What is the market cap of Medico Intercontinental Ltd (MIL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medico Intercontinental Ltd (MIL) is ₹40.91 Cr as of 12th June 2025.What is the 52 week high and low of Medico Intercontinental Ltd (MIL) share?
The 52-week high of Medico Intercontinental Ltd (MIL) is ₹63.59 and the 52-week low is ₹34.21.What is the PE and PB ratio of Medico Intercontinental Ltd (MIL) stock?
The P/E (price-to-earnings) ratio of Medico Intercontinental Ltd (MIL) is 8.10. The P/B (price-to-book) ratio is 0.91.Which sector does Medico Intercontinental Ltd (MIL) belong to?
Medico Intercontinental Ltd (MIL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Medico Intercontinental Ltd (MIL) shares?
You can directly buy Medico Intercontinental Ltd (MIL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Medico Intercontinental Ltd
MIL Share Price
40.800.27% (-0.11)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MIL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MIL Performance & Key Metrics
MIL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 8.10 | 0.91 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.27 | 6.67 | 0.83% |
MIL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
MIL Company Profile
Medico Intercontinental Ltd is engaged in the trading of pharmaceutical products
SUNPHARMA
PE Ratio
37.12
37.12
1Y Return
11.98%
11.98%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
23.31
23.31
1Y Return
2.48%
2.48%
Buy Reco %
74.19
74.19
DRREDDY
PE Ratio
19.88
19.88
1Y Return
12.43%
12.43%
Buy Reco %
56.67
56.67
TORNTPHARM
PE Ratio
56.78
56.78
1Y Return
12.62%
12.62%
Buy Reco %
72.00
72.00
ZYDUSLIFE
PE Ratio
21.76
21.76
1Y Return
10.77%
10.77%
Buy Reco %
48.28
48.28
MIL Forecast
MIL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
MIL
MIL
Income
Balance Sheet
Cash Flow
Annual Normal View
MIL Income Statement
MIL Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.39 | 10.31 | 82.01 | 69.92 | 74.57 | 76.74 | 71.76 | 96.37 | 96.37 | |||||||||
Raw Materials | 0.21 | 9.53 | 75.18 | 58.05 | 59.61 | 63.30 | 56.43 | 87.59 | 87.59 | |||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.06 | 0.06 | 0.17 | 0.06 | 0.07 | |||||||||||
| Employee Cost | 0.06 | 0.03 | 3.01 | 1.81 | 1.75 | 2.47 | 2.97 | |||||||||||
| Selling & Administrative Expenses | 0.07 | 0.32 | 4.91 | 5.31 | 6.24 | 5.95 | 7.42 | |||||||||||
| Operating & Other expenses | -0.00 | -0.58 | -5.55 | -0.26 | 1.48 | -0.81 | -1.35 | |||||||||||
EBITDA | 0.05 | 1.01 | 4.40 | 4.95 | 5.32 | 5.77 | 6.22 | 8.78 | 8.78 | |||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.10 | 0.14 | 0.21 | 0.20 | 0.29 | 0.81 | 0.81 | |||||||||
| PBIT | 0.05 | 1.01 | 4.30 | 4.81 | 5.11 | 5.57 | 5.93 | 7.97 | 7.97 | |||||||||
| Interest & Other Items | 0.00 | 0.01 | 1.10 | 1.28 | 0.88 | 0.62 | 0.50 | 1.00 | 0.99 | |||||||||
| PBT | 0.05 | 1.00 | 3.20 | 3.53 | 4.23 | 4.95 | 5.43 | 6.97 | 6.98 | |||||||||
| Taxes & Other Items | 0.02 | 0.27 | 0.84 | 0.95 | 1.13 | 1.34 | 1.49 | 1.92 | 1.93 | |||||||||
| Net Income | 0.03 | 0.73 | 2.36 | 2.58 | 3.10 | 3.61 | 3.94 | 5.05 | 5.05 | |||||||||
| EPS | 0.09 | 2.25 | 7.26 | 7.94 | 9.54 | 5.45 | 3.94 | 5.06 | 5.05 | |||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.10 | 0.00 | 0.00 | |||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.00 | 0.00 |
MIL Company Updates
MIL Stock Peers
MIL Past Performance & Peer Comparison
MIL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Medico Intercontinental Ltd | 8.10 | 0.91 | — |
| Sun Pharmaceutical Industries Ltd | 37.12 | 6.04 | 0.95% |
| Cipla Ltd | 23.31 | 4.59 | 1.05% |
| Dr Reddy's Laboratories Ltd | 19.88 | 3.98 | 0.59% |
MIL Stock Price Comparison
Compare MIL with any stock or ETFCompare MIL with any stock or ETF
MIL
MIL Holdings
MIL Shareholdings
MIL Promoter Holdings Trend
MIL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MIL Institutional Holdings Trend
MIL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MIL Shareholding Pattern
MIL Shareholding Pattern
MIL Shareholding History
MIL Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MIL stock
smallcases containing MIL stock
Looks like this stock is not in any smallcase yet.
MIL Events
MIL Events
MIL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MIL Dividend Trend
No dividend trend available
MIL Upcoming Dividends
MIL Upcoming Dividends
No upcoming dividends are available
MIL Past Dividends
MIL Past Dividends
Cash Dividend
Ex DateEx DateJun 23, 2023
Final
Final | Div/Share: ₹0.10
Dividend/Share
₹0.10
Ex DateEx Date
Jun 23, 2023
MIL Stock News & Opinions
MIL Stock News & Opinions
Articles & Videos
Earnings
Medico Intercontinental consolidated net profit rises 12.50% in the March 2025 quarter
Net profit of Medico Intercontinental rose 12.50% to Rs 1.17 crore in the quarter ended March 2025 as against Rs 1.04 crore during the previous quarter ended March 2024. Sales rose 36.24% to Rs 21.39 crore in the quarter ended March 2025 as against Rs 15.70 crore during the previous quarter ended March 2024. For the full year,net profit rose 28.10% to Rs 5.06 crore in the year ended March 2025 as against Rs 3.95 crore during the previous year ended March 2024. Sales rose 34.56% to Rs 96.02 crore in the year ended March 2025 as against Rs 71.36 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales21.3915.70 36 96.0271.36 35 OPM %9.359.87 -8.778.16 - PBDT1.811.53 18 7.785.73 36 PBT1.521.44 6 6.975.44 28 NP1.171.04 13 5.063.95 28 Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Medico Intercontinental schedules board meeting
Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
Medico Intercontinental consolidated net profit rises 14.71% in the December 2024 quarter
Net profit of Medico Intercontinental rose 14.71% to Rs 1.17 crore in the quarter ended December 2024 as against Rs 1.02 crore during the previous quarter ended December 2023. Sales rose 34.39% to Rs 19.15 crore in the quarter ended December 2024 as against Rs 14.25 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales19.1514.25 34 OPM %10.5010.39 - PBDT1.861.45 28 PBT1.621.38 17 NP1.171.02 15 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Medico Intercontinental to declare Quarterly Results
Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Medico Intercontinental consolidated net profit rises 87.36% in the September 2024 quarter
Net profit of Medico Intercontinental rose 87.36% to Rs 1.63 crore in the quarter ended September 2024 as against Rs 0.87 crore during the previous quarter ended September 2023. Sales rose 117.52% to Rs 37.24 crore in the quarter ended September 2024 as against Rs 17.12 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales37.2417.12 118 OPM %7.497.71 - PBDT2.551.30 96 PBT2.341.23 90 NP1.630.87 87 Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Medico Intercontinental standalone net profit rises 106.25% in the September 2024 quarter
Net profit of Medico Intercontinental rose 106.25% to Rs 0.99 crore in the quarter ended September 2024 as against Rs 0.48 crore during the previous quarter ended September 2023. Sales rose 195.01% to Rs 28.94 crore in the quarter ended September 2024 as against Rs 9.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales28.949.81 195 OPM %5.814.99 - PBDT1.600.71 125 PBT1.450.66 120 NP0.990.48 106 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Medico Intercontinental to table results
Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Medico Intercontinental to convene AGM
Medico Intercontinental announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Medico Intercontinental consolidated net profit rises 5.88% in the June 2024 quarter
Net profit of Medico Intercontinental rose 5.88% to Rs 1.08 crore in the quarter ended June 2024 as against Rs 1.02 crore during the previous quarter ended June 2023. Sales declined 24.92% to Rs 18.23 crore in the quarter ended June 2024 as against Rs 24.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.2324.28 -25 OPM %8.896.10 - PBDT1.571.45 8 PBT1.491.38 8 NP1.081.02 6 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Medico Intercontinental to conduct board meeting
Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 47.41%, vs industry avg of 9.02%
Over the last 5 years, market share increased from 0% to 0.02%
Over the last 5 years, net income has grown at a yearly rate of 40.1%, vs industry avg of 15.29%